Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
Abstract To date, only few data concerning the biologically active, free form of testosterone (FT) are available in metastatic prostate cancer (mPC) and the impact of FT on disease, therapy and outcome is largely unknown. We retrospectively studied the effect of docetaxel on FT and total testosteron...
Guardado en:
Autores principales: | Paula Kappler, Michael A. Morgan, Philipp Ivanyi, Stefan J. Brunotte, Arnold Ganser, Christoph W. M. Reuter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a789714755e147bb96b1cf2cae3cdbfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
por: Minami Une, et al.
Publicado: (2021) -
Relationship between serum total testosterone and prostate volume in aging men
por: Bo-Wen Xia, et al.
Publicado: (2021) -
Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
por: Lixian Zhong, et al.
Publicado: (2013) -
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Qi Wang, et al.
Publicado: (2017) -
Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
por: Victoria J Sinibaldi
Publicado: (2008)